42 min listen
Questions Answered on ART Safety and Tolerability in Pregnant People and Transgender Individuals
Questions Answered on ART Safety and Tolerability in Pregnant People and Transgender Individuals
ratings:
Length:
23 minutes
Released:
Feb 23, 2023
Format:
Podcast episode
Description
In this episode, Jill Blumenthal, MD, MAS, and William R. Short, MD, MPH, AAHIVS, address key considerations when evaluating ART safety and tolerability in pregnant people, those trying to conceive, and transgender individuals, such as:Approaching patients trying to conceive on nonpreferred ART regimens (eg, 2-drug regimens like LA CAB and RPV)Optimizing the use of the Antiretroviral Pregnancy RegistryAddressing unique barriers to ARV adherence in transgender individuals with HIV (eg, drug formulation considerations for ARV medications and gender-affirming hormone therapy, sperm banking or egg harvesting, drug coverage considerations)Faculty: Jill Blumenthal, MD, MASAssociate Professor of MedicineInfectious Diseases and Global Public Health University of California, San DiegoSan Diego, CaliforniaWilliam R. Short, MD, MPH, AAHIVSAssociate Professor of MedicineDivision of Infectious Diseases Department of Medicine Perelman School of Medicine at the University of Pennsylvania Philadelphia, PennsylvaniaLink to full program:http://bit.ly/3PM3nYeLink to downloadable slides: http://bit.ly/3WgYycz
Released:
Feb 23, 2023
Format:
Podcast episode
Titles in the series (100)
Contemporary Management of HIV: ART Strategies for Complex HIV Cases: Listen to expert insights from Joseph J. Eron, Jr., MD, and Jason Halperin, MD, MPH, on optimal management of complex HIV cases, including switching ART in a patient with potential underlying resistance and initiating ART in a patient with obesity. by CCO Infectious Disease Podcast